Real Life Cancer Comorbidity in Greek Patients with Diabetes Mellitus Followed Up at a Single Diabetes Center: An Unappreciated New Diabetes Complication

Table 1

Characteristics of regularly followed-up subjects with cancer in comparison to subjects without cancer.

	T2DM			T1DM
	CA +; (𝑛=96); 12.6%	CA −; (𝑛=663)	𝑃	CA +; (𝑛=4); 3.0%	CA −; (𝑛=127)	𝑃
Sex (males)	63.5%	57.9%	NS	50.0%	50.0%	NS
Age	70.9 ± 1.0	68.3 ± 0.4	<0.05	49.0 ± 9.0	46.4 ± 1.3	NS
Age of diabetes onset	51.2 ± 1.1	48.9 ± 0.4	<0.05	37.7 ± 8.7	23.4 ± 1.2	<0.05
Diabetes duration (years)	20.8 ± 0.9	19.5 ± 0.3	NS	11.5 ± 0.6	23.5 ± 0.9	<0.05
Smoking	66.7%	50.8%	<0.01	50.0%	47.9%	NS
BMI	28.5 ± 0.4	28.5 ± 0.2	NS	30.2 ± 2.2	25.5 ± 0.3	NS
Weight (kg) (males)	79.9 ± 1.5	80.1 ± 0.6	NS	95.5 ± 7.5	80.0 ± 1.3	NS
Weight (kg) (females)	75.8 ± 1.7	73.7 ± 0.9	NS	75.0 ± 18.0	65.3 ± 1.4	NS
Height (m) (males)	1.70 ± 0.0	1.70 ± 0.0	NS	1.83 ± 0.1	1.80 ± 0.0	NS
Height (m) (females)	1.58 ± 0.0	1.58 ± 0.0	NS	1.52 ± 0.0	1.60 ± 0.0	NS
Waist (cm) (males)	99.8 ± 1.2	99.1 ± 0.9	NS	101.2 ± 5.1	98.9 ± 1.3	NS
Waist (cm) (females)	95.8 ± 1.6	96.5 ± 0.3	NS	97.9 ± 1.1	87.6 ± 1.1	NS
SAP (mmHg)	138.2 ± 1.4	133.6 ± 1.5	NS	130.3 ± 1.0	129.6 ± 1.2	NS
DAP (mmHg)	79.6 ± 1.2	74.8 ± 0.8	NS	73.2 ± 0.2	75.8 ± 0.6	NS
A1c%	7.0 ± 0.1	7.0 ± 0.0	NS	8.1 ± 0.4	7.5 ± 0.4	NS
OADs (%)	53.1%	60.0%	NS
OADs + basal insulin (%)	13.5%	8.7%	NS
Insulin treated (%)	33.3%	31.2%	NS
Years of diabetes before insulin initiation	16.3 ± 1.2	14.9 ± 0.5	NS
Duration of insulin therapy (years)	7.2 ± 1.0	7.2 ± 0.4	NS
“Classical” diabetes complications coexistence (%)	57.1%	68.8%	NS	66.7%	47.4%	NS

OADs: oral antidiabetic drugs.